Medical News

RSS

Republicans start new effort to advance greater federal abortion funding restrictions

The Hill: House Minority Leader John Boehner will introduce legislation that would stop Congress from using taxpayer money to support abortions or abortion coverage.

28 Jun 2010

PURE Bioscience qualifies for Russell 3000, Russell 2000 Indexes

PURE Bioscience today announced that it has been added to the Russell 3000® and Russell 2000® Indexes, which measure the performance of the largest U.S. companies based on total market capitalization. The Russell 2000 is the smaller 2,000 companies within the larger index. The annual reconstitution of the Russell Indexes occurred on Friday, June 25th.

28 Jun 2010

MagForce's Nano-Cancer therapy receives European regulatory approval

Following two decades of intensive research and development efforts, MagForce Nanotechnologies AG, a Berlin-based medical technology company founded in 1997, has received European regulatory approval for its Nano-Cancer® therapy.

28 Jun 2010

States struggle with physician shortages, health care workforce issues

Worcester (Mass.) Telegram & Gazette, reports on a national shortage of pediatric subspecialists. "While Massachusetts has more pediatric sub-specialists per capita than many other states, the doctors are in short supply, even at big institutions like UMass. … Pediatric sub-specialists go through several years of training: four years of medical school, three years of training in pediatrics, then another three years of training in a specialty," yet their salaries are not much higher than regular pediatricians.

28 Jun 2010

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

Picis announced today that Bayonne Medical Center, Bayonne, NJ, has successfully deployed Picis ED PulseCheck™, part of the CareSuite® family of high-acuity solutions, two months ahead of schedule. This aggressive implementation is aimed at helping clinicians in the emergency department (ED) better manage information and the process of treating over 28,000 ED patients annually.

28 Jun 2010

Arteriocyte honored as Venture of Year Award Finalist

Arteriocyte, Inc., was honored Friday by the Ohio Venture Association as a Venture of Year Award Finalist. Founded in 2004 to develop proprietary stem cell and tissue engineering based therapies, Arteriocyte focuses on developing commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral cord blood, and cartilage) for delivery to injured tissues in order to speed repair and improve function.

28 Jun 2010

Tricare to allow civilian employers of military retirees to offer cafeteria insurance plans

Tricare is allowing civilian employers of military retirees to offer a cafeteria-style supplemental health insurance plan so that "workers who elect to use their Tricare Standard benefit can buy coverage conveniently and with pre-taxed dollars," The Colorado Springs Gazette reports. A former law prohibited employers from "enticing retirees to use Tricare instead of employer-paid insurance."

28 Jun 2010

Rexahn announces $10 million registered direct offering

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced it has received commitments from certain institutional investors to purchase an aggregate of $10 million of Rexahn's securities in a registered direct offering.

28 Jun 2010

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

Yesterday, the Association for Molecular Pathology (AMP) gave public comments at the FDA's Center for Devices and Radiological Health (CDRH) Council meeting on Medical Device Innovation: Barriers to Market for Molecular Diagnostic Tests.

28 Jun 2010

Pittsburgh companies using wellness to try to keep health costs down

Pittsburgh companies are using wellness incentives in the workplace to trim their health care costs as "small businesses prepare for a lift in their efforts to keep workers healthy, courtesy of health care reform," the Pittsburgh Business Times reports.

28 Jun 2010

Fireworks Safety Tips from AMR paramedics

The Independence Day holiday is filled with the bangs, whistles and pops of backyard fireworks. Too often, revelers forget that fireworks are dangerous explosives, not toys. Fireworks send thousands of people to the hospital each year and cause millions of dollars in fire losses. Here's some fireworks safety advice from paramedics at American Medical Response (AMR) to help protect you and your family from injury and property damage.

28 Jun 2010

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Biomet, Inc. announced today fourth quarter and fiscal year 2010 preliminary net sales results for the year ended May 31, 2010.

28 Jun 2010

Today's OpEds: A new breed of medical education, more on the Medicare 'doc fix,' efforts to cut health care waste

Medical schools in particular may transform the way healthcare is practiced and viewed by the general community and its leaders. The medical school with this focus will not only pursue traditional missions like research and teaching students diagnostic skills but also emphasize community involvement, local medicine, social consciousness and local cultural issues (Dr. John Rock, 6/28).

28 Jun 2010

Inhibitex joins Russell 3000 Index

Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.

28 Jun 2010

ULURU, Strakan International divest interest in Zindaclin to Crawford Healthcare subsidiary

ULURU Inc. announced today that Strakan International Limited and ULURU have divested their respective interest in Zindaclin® to a subsidiary of Crawford Healthcare Limited, a pharmaceutical company based in England. Zindaclin® is a product for the treatment of acne which is outside the strategic focus of ULURU. This product was included in the technology package ULURU acquired when it was formed in 2005.

28 Jun 2010

FUJINON restructured into two subsidiaries

FUJIFILM Holdings America Corporation, today announced that FUJINON INC. will be restructured into two subsidiaries - one will report into FUJIFILM North America Corporation and the other into FUJIFILM Medical Systems U.S.A., Inc. This restructuring of Fujinon into two subsidiary companies will support Fujifilm's objective of strengthening its sales organizations to realize future growth.

28 Jun 2010

Medicare turns to more comprehensive tools to find fraud

Federal Times: The Recovery Board, which oversees the $275 billion economic stimulus package that was approved by the federal government in 2009, is using a software platform from Palantir Technologies, based in Palo Alto, Calif. "The software tool analyzes information contained on various government-maintained databases — GSA's list of suspended or debarred contractors, the Treasury Department's financial crimes network and other law enforcement records — along with open-source data such as newspaper articles, lawsuits and other public documents.

28 Jun 2010

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

28 Jun 2010

KHN column: The Medicare 'doc fix': How to make political lemonade

In his latest Kaiser Health News column, Austin Frakt writes: "The mechanism that governs the growth rate of Medicare spending on physician services isn't working.

28 Jun 2010

Zeria reports positive results from Japanese Phase III study of Z-338 for functional dyspepsia

Zeria Pharmaceutical announced today positive results of their Japanese Phase III study of Z-338 (acotiamide hydrochloride hydrate; "acotiamide") for the treatment of functional dyspepsia (FD). FD is a gastrointestinal disease comprised of subjective symptoms including postprandial fullness, early satiation and epigastric pain without any organic abnormality on gastrointestinal tract.

28 Jun 2010

Medical News

Republicans start new effort to advance greater federal abortion funding restrictions

PURE Bioscience qualifies for Russell 3000, Russell 2000 Indexes

MagForce's Nano-Cancer therapy receives European regulatory approval

States struggle with physician shortages, health care workforce issues

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

Arteriocyte honored as Venture of Year Award Finalist

Tricare to allow civilian employers of military retirees to offer cafeteria insurance plans

Rexahn announces $10 million registered direct offering

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

Pittsburgh companies using wellness to try to keep health costs down

Fireworks Safety Tips from AMR paramedics

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Today's OpEds: A new breed of medical education, more on the Medicare 'doc fix,' efforts to cut health care waste

Inhibitex joins Russell 3000 Index

ULURU, Strakan International divest interest in Zindaclin to Crawford Healthcare subsidiary

FUJINON restructured into two subsidiaries

Medicare turns to more comprehensive tools to find fraud

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

KHN column: The Medicare 'doc fix': How to make political lemonade

Zeria reports positive results from Japanese Phase III study of Z-338 for functional dyspepsia

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News